ANDREWS GLEN IAN,CHEN SHIHAO,DI PIETRO ALESSANDRA,FONTANA DAVID,GOLDBERG ZELANNA,LIN CHIA YANG,LONG HUA,MARTIGNONI MARCELLA,NUYTEN DIMITRY SERGE ANTOINE,THALL ARON DAVID,WOOLFSON ADRIAN
申请号:
IN201837001206
公开号:
IN201837001206A
申请日:
2018.01.11
申请国别(地区):
IN
年份:
2018
代理人:
摘要:
The present disclosure describes combination therapies comprising an antagonist of Programmed Death Ligand 1 receptor (PD L1) and another therapeutic agent and the use of the combination therapies for the treatment of cancer.